Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY27.11 CNY
Change Today +0.47 / 1.76%
Volume 1.1M
As of 11:14 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

hangzhou tian-mu-shan phar-a (600671) Snapshot

Open
CNY26.91
Previous Close
CNY26.64
Day High
CNY27.56
Day Low
CNY24.30
52 Week High
06/18/15 - CNY35.20
52 Week Low
08/4/14 - CNY13.40
Market Cap
3.3B
Average Volume 10 Days
3.2M
EPS TTM
CNY-0.01
Shares Outstanding
121.8M
EX-Date
08/24/08
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HANGZHOU TIAN-MU-SHAN PHAR-A (600671)

Related News

No related news articles were found.

hangzhou tian-mu-shan phar-a (600671) Related Businessweek News

No Related Businessweek News Found

hangzhou tian-mu-shan phar-a (600671) Details

Hangzhou TianMuShan Pharmaceutical Enterprise Co., Ltd manufactures and distributes pharmaceuticals, healthcare products, and medical equipment in China. The company offers its pharmaceutical products in the form of granules, eye drops, soft capsules, oral liquids, tablets, pills, capsules, and others. Its products include Pearl eyesight drops, Dendrobium soft capsules, Ho created capsules, Fule particles, Xianzhuli liquid compounds, and Lily solid gold liquids, as well as Liuweidihuang oral liquid products, such as peppermint oil, menthol, etc. The company is also involved in the biological products manufacture and distribution; food distribution; technology development; investment management; and other activities. Hangzhou TianMuShan Pharmaceutical Enterprise Co., Ltd was founded in 1958 and is based in Lin'an City, China.

Founded in 1958

hangzhou tian-mu-shan phar-a (600671) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hangzhou tian-mu-shan phar-a (600671) Key Developments

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, Board Meeting, Jul 09, 2015

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, Board Meeting, Jul 09, 2015. Agenda: To discuss and approve the proposal of Members of the Special Committees of the 9th Directorate.

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd Elects He Shunming as Chair of Directorate

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd approved the proposal of electing He Shunming as Chair of Directorate at its first session of the ninth directorate meeting held on June 26, 2015.

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, Board Meeting, Jun 26, 2015

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, Board Meeting, Jun 26, 2015. Agenda: To discuss and approve the proposal of electing He Shunming as chair of directorate.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600671:CH CNY27.11 CNY +0.47

600671 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600671.
View Industry Companies
 

Industry Analysis

600671

Industry Average

Valuation 600671 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 24.5x
Price/Book 41.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 23.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HANGZHOU TIAN-MU-SHAN PHAR-A, please visit www.hztmyy.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.